title: Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer.
authors.affiliation: Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. khoffman2@mdanderson.org
authors.forename: Karen E
authors.initials: KE
authors.lastname: Hoffman
authors.forename: Ming-Hui
authors.initials: MH
authors.lastname: Chen
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Moran
authors.forename: Michelle H
authors.initials: MH
authors.lastname: Braccioforte
authors.forename: Daniel
authors.initials: D
authors.lastname: Dosoretz
authors.forename: Sharon
authors.initials: S
authors.lastname: Salenius
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Katin
authors.forename: Rudi
authors.initials: R
authors.lastname: Ross
authors.forename: Anthony V
authors.initials: AV
authors.lastname: D'Amico
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001918:Brachytherapy; D002318:Cardiovascular Diseases / Q000150:complications; D002423:Cause of Death; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D050397:Radiotherapy, Intensity-Modulated
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal